CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q221 Q321 Q421 Q122 Q222 Q322 Q422 Q123 Q223 Revenues: Clearing and transaction fees 929.9 878.9 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 Market data and information services 145.2 145.4 142.1 151.7 151.7 154.3 153.2 165.8 163.1 Other Revenue 104.1 85.6 55.9 56.8 60.9 74.9 73.2 75.6 78.8 Total revenues 1,179.2 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 Expenses: Compensation and benefits 211.7 198.6 201.7 185.2 185.3 189.6 193.0 204.5 205.7 Technology 49.3 49.3 45.8 45.9 45.9 46.8 50.0 51.3 53.3 Professional fees and outside services 36.8 45.2 32.3 31.8 32.0 35.1 38.5 38.3 37.8 Amortization of purchased intangibles 59.4 59.0 58.6 58.4 57.1 55.5 56.7 56.8 57.0 Depreciation and amortization 37.1 37.2 35.9 33.5 33.0 34.5 33.9 31.9 32.3 Licensing and other fee agreements 54.2 57.6 60.4 80.9 83.1 83.6 72.4 84.7 78.2 Other expense 56.0 49.3 80.9 51.8 51.1 43.9 95.0 60.4 57.3 Operating expenses 504.5 496.2 515.6 487.5 487.5 489.0 539.5 527.9 521.6 Operating Income 674.7 613.7 631.7 859.1 749.7 738.8 668.3 913.7 838.6 Operating Margin 57% 55% 55% 64% 61% 60% 55% 63% 62% Non-operating Income and Expense Investment income 62.4 145.8 67.8 73.1 286.9 686.2 1,152.2 1,357.7 1,568.2 Interest and other borrowing costs (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) Equity in net gains (losses) of unconsolidated subsidiaries 55.7 66.4 67.5 73.3 87.3 76.5 64.0 78.2 75.1 Other non-operating income (expense) (25.0) 311.8 74.2 (46.7) (217.3) (581.1) (1,017.3) (1,152.8) (1,425.3) Non-operating income (expense) 51.4 482.2 167.6 57.2 117.0 141.2 159.0 243.2 177.8 Income before income taxes 726.1 1,095.9 799.3 916.3 866.7 880.0 827.3 1,156.9 1,016.4 Income taxes 215.5 169.6 174.1 205.3 204.2 200.4 189.4 273.1 238.8 Net income 510.6 926.3 625.2 711.0 662.5 679.6 637.9 883.8 777.6 Less: net income (loss) attributable to NCI 0.3 (0.2) - - - - - - - Net Income Attributable to CME Group 510.3 926.5 625.2 711.0 662.5 679.6 637.9 883.8 777.6 Net Income Attributable to Common Shareholders of CME Group 510.3 926.5 613.3 702.0 654.1 671.1 629.9 872.7 767.8 Effective Tax Rate 29.7% 15.5% 21.8% 22.4% 23.6% 22.8% 22.8% 23.6% 23.5% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.42 2.59 1.71 1.96 1.82 1.87 1.76 2.43 2.14 Diluted EPS 1.42 2.58 1.71 1.95 1.82 1.87 1.75 2.43 2.14 Weighted average number of common stock shares: Basic Shares 358,261 358,363 358,582 358,609 358,641 358,715 358,885 358,933 358,940 Diluted Shares 358,888 358,988 359,019 359,180 359,205 359,288 359,190 359,313 359,429 Preferred Shares 2,890 4,584 4,584 4,584 4,584 4,584 4,584 -- 1 of 2 -- CME GROUP INC. AND SUBSIDIARIES CONSOLIDATED STATEMENTS OF NON-GAAP INCOME QUARTER ENDED (dollars in millions, except per share data; shares in thousands) Q221 Q321 Q421 Q122 Q222 Q322 Q422 Q123 Q223 Revenues: Clearing and transaction fees 929.9 878.9 949.3 1,138.1 1,024.6 998.6 981.4 1,200.2 1,118.3 Market data and information services 145.2 145.4 142.1 151.7 151.7 154.3 153.2 165.8 163.1 Other Revenue 101.0 85.6 55.9 56.8 60.9 74.9 73.2 75.6 78.8 Total revenues 1,176.1 1,109.9 1,147.3 1,346.6 1,237.2 1,227.8 1,207.8 1,441.6 1,360.2 Expenses: Compensation and benefits 201.9 191.1 183.7 182.8 189.5 189.1 184.6 192.8 194.4 Technology 49.2 49.1 45.6 45.8 45.9 46.8 50.0 51.3 53.3 Professional fees and outside services 30.0 26.5 27.2 30.3 31.4 35.1 38.5 38.3 37.8 Amortization of purchased intangibles - - - - - - - - - Depreciation and amortization 36.7 36.7 35.6 33.5 32.9 33.8 33.9 31.9 31.8 Licensing and other fee agreements 54.2 57.6 60.4 80.9 83.1 81.9 72.4 84.7 78.2 Other expense 54.8 51.3 76.5 51.7 59.6 54.4 84.5 59.7 56.2 Operating expenses 426.8 412.3 429.0 425.0 442.4 441.1 463.9 458.7 451.7 Operating Income 749.3 697.6 718.3 921.6 794.8 786.7 743.9 982.9 908.5 Operating Margin 64% 63% 63% 68% 64% 64% 62% 68% 67% Non-operating Income and Expense Investment income 37.3 55.1 58.2 74.7 299.5 688.5 1,147.1 1,277.5 1,564.0 Interest and other borrowing costs (41.7) (41.8) (41.9) (42.5) (39.9) (40.4) (39.9) (39.9) (40.2) Equity in net gains (losses) of unconsolidated subsidiaries 55.7 70.5 78.7 84.7 98.2 89.6 76.2 91.5 88.6 Other non-operating income (expense) (25.0) (32.9) (33.0) (43.4) (218.5) (585.7) (1,023.3) (1,160.6) (1,429.9) Non-operating income (expense) 26.3 50.9 62.0 73.5 139.3 152.0 160.1 168.5 182.5 Income before income taxes 775.6 748.5 780.3 995.1 934.1 938.7 904.0 1,151.4 1,091.0 Income taxes 186.7 174.3 172.8 228.9 217.6 219.6 206.0 269.1 254.6 Net income 588.9 574.2 607.5 766.2 716.5 719.1 698.0 882.3 836.4 Less: net income (loss) attributable to NCI 0.3 (0.2) - - - - - - - Net Income Attributable to CME Group 588.6 574.4 607.5 766.2 716.5 719.1 698.0 882.3 836.4 Net Income Attributable to Common Shareholders of CME Group 588.6 574.4 595.7 756.6 707.5 710.0 689.1 871.1 825.9 Effective Tax Rate 24.1% 23.3% 22.1% 23.0% 23.3% 23.4% 22.8% 23.4% 23.3% Earnings per Share Attributable to Common Shareholders of CME Group: Basic EPS 1.64 1.60 1.66 2.11 1.97 1.98 1.92 2.43 2.30 Diluted EPS 1.64 1.60 1.66 2.11 1.97 1.98 1.92 2.42 2.30 Weighted average number of common stock shares: Basic Shares 358,261 358,363 358,582 358,609 358,641 358,715 358,885 358,933 358,940 Diluted Shares 358,888 358,988 359,019 359,180 359,205 359,288 359,190 359,313 359,429 Preferred Shares - - 2,890 4,584 4,584 4,584 4,584 4,584 4,584 -- 2 of 2 --